Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106673747 | 10667374 | 7 | F | 2007 | 20160825 | 20141222 | 20160829 | EXP | US-009507513-1110USA04072 | MERCK | 0.00 | M | Y | 81.63000 | KG | 20160829 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106673747 | 10667374 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | 20788 | 1 | MG | FILM-COATED TABLET | QD | ||||||
| 106673747 | 10667374 | 2 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | UNK, UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106673747 | 10667374 | 1 | Alopecia |
| 106673747 | 10667374 | 2 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106673747 | 10667374 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106673747 | 10667374 | Abdominal distension | |
| 106673747 | 10667374 | Anxiety | |
| 106673747 | 10667374 | Basilar migraine | |
| 106673747 | 10667374 | Blood pressure increased | |
| 106673747 | 10667374 | Cholelithiasis | |
| 106673747 | 10667374 | Cognitive disorder | |
| 106673747 | 10667374 | Dependence | |
| 106673747 | 10667374 | Depression | |
| 106673747 | 10667374 | Dry skin | |
| 106673747 | 10667374 | Ear operation | |
| 106673747 | 10667374 | Erectile dysfunction | |
| 106673747 | 10667374 | Exposure to toxic agent | |
| 106673747 | 10667374 | Fatigue | |
| 106673747 | 10667374 | Flatulence | |
| 106673747 | 10667374 | Fracture | |
| 106673747 | 10667374 | Frustration tolerance decreased | |
| 106673747 | 10667374 | Hypogonadism | |
| 106673747 | 10667374 | Hypopituitarism | |
| 106673747 | 10667374 | Injury | |
| 106673747 | 10667374 | Irritability | |
| 106673747 | 10667374 | Libido decreased | |
| 106673747 | 10667374 | Memory impairment | |
| 106673747 | 10667374 | Migraine | |
| 106673747 | 10667374 | Muscle fatigue | |
| 106673747 | 10667374 | Muscular weakness | |
| 106673747 | 10667374 | Nasal congestion | |
| 106673747 | 10667374 | Nasopharyngitis | |
| 106673747 | 10667374 | Palpitations | |
| 106673747 | 10667374 | Premature ejaculation | |
| 106673747 | 10667374 | Prostatic specific antigen increased | |
| 106673747 | 10667374 | Sedation | |
| 106673747 | 10667374 | Semen volume decreased | |
| 106673747 | 10667374 | Sexual dysfunction | |
| 106673747 | 10667374 | Skin lesion | |
| 106673747 | 10667374 | Somnolence | |
| 106673747 | 10667374 | Stress | |
| 106673747 | 10667374 | Testicular pain | |
| 106673747 | 10667374 | Vision blurred | |
| 106673747 | 10667374 | Visual impairment | |
| 106673747 | 10667374 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106673747 | 10667374 | 1 | 2007 | 2009 | 0 | |
| 106673747 | 10667374 | 2 | 20080513 | 20080905 | 0 |